T Cell Transfer With or Without Dendritic Cell Vaccination in Patients With Melanoma
Status:
Recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn if dendritic cell vaccine will increase the effect of
tumor infiltrating lymphocytes given with chemotherapy and interleukin-2 in patients with
melanoma.